Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc., Endo Health Solutions Inc., Par...
Endo International plc (NASDAQ: ENDP) today reported second-quarter 2019 financial results, including: Revenues of $700 million, a decrease of 2...
Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2019 financial results on August 6, 2019 and members of its senior management...
Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2018 financial results on November 8, 2018 and members of its senior management ...
Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its fourth quarter 2015 financial results before the open of the U.S. financial...
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ:...
Transaction valued at $8.05 billion is transformative for Endo, creating a powerful platform for future growth and further strategic M&A Creates...
Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that Rajiv De Silva, President and CEO, will present a corporate overview at the...
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) ...
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions (Nasdaq: ENDP), announced today that the company has received Paragraph IV...
Endo Pharmaceuticals and Bioniche Life Sciences today presented Phase III trial results for the intravesical formulation of Mycobacterial cell...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.